好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Wireless, Wearable, Soft Electronics for Blepharospasm Assessment
Movement Disorders
P4 - Poster Session 4 (5:30 PM-6:30 PM)
10-006
To develop a wearable, soft material-enabled device for objective kinematic measurement of the severity and fluctuations of blepharospasm symptoms.

Blepharospasm (BSP) is characterized by stereotyped, bilateral, and synchronous spasm of the orbicularis oculi muscles. Additional motor manifestations include apraxia of eyelid opening and increased blink rate. Current rating scales for BSP are subjective, based on rater observation, and therefore limited in their ability to measure these motor manifestations and guide treatment. Accurate measurement of BSP symptoms is critical for optimization of clinical care for this particularly disabling condition and for future clinical trials.

Subjects with a diagnosis of idiopathic BSP were recruited. The severity of BSP was assessed using the current validated clinical rating scales. Objective data quantifying dystonic movements were obtained using a set of soft, stretchable, gel-free electrodes which were placed over the frontalis and a portion of the orbicularis oculi to measure movements. Portable, miniaturized wireless electronics were utilized to record the signals via an Android smartphone. To analyze the real-time recorded data, we used a deep-learning method (convolutional neural network) that was embedded in the smartphone. The newly developed software offered an automatic, simultaneous detection of the motor manifestations of BSP along with a digital scale severity.

Preliminary analysis of objective data from 6 patients suggests that the wearable soft electronic is sensitive to detect muscle spasm, blink rate, and apraxia of eyelid opening related to BSP. Recruitment is ongoing and detailed results will be presented.
Preliminary analysis reveals that this wearable device can reliably detect the motor manifestations of BSP. Further testing is planned to determine how sensitive the device is to fluctuations in severity and treatment response. This novel technology has the potential to dramatically improve clinical practice and clinical trial design for BSP.
Authors/Disclosures
Laura M. Scorr, MD
PRESENTER
Dr. Scorr has received research support from Dystonia Medical Research Foundation.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
H. A. Jinnah, MD, PhD, FAAN (Emory University) Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.